0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Natamycin Market Research Report 2026
Published Date: 2026-02-03
|
Report Code: QYRE-Auto-28W2310
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Natamycin Market Insights and Forecast to 2028
BUY CHAPTERS

Global Natamycin Market Research Report 2026

Code: QYRE-Auto-28W2310
Report
2026-02-03
Pages:124
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Natamycin Market Size

The global Natamycin market was valued at US$ 222 million in 2025 and is anticipated to reach US$ 341 million by 2032, at a CAGR of 6.4% from 2026 to 2032.

Natamycin Market

Natamycin Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Natamycin competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Natamycin, also sold as Natacyn, is a type of white powder that fermented by the bacterium Streptomyces natalensis. Natamycin has an ability to inhibit fungal growth but cannot inhibit the growth of bacteria, it is often used in food industry like yogurt, cheese, raw ham, dry sausage as a natural preservative. Natamycin can also be used in medicine to treat diseases caused by fungi.
Global Natamycin key players include Danisco, DSM, VGP, Handary, AMTECH BIOTECH, etc. Global top five players hold a share about 50%.
North America is the largest market, with a share about 35%, followed by Europe and China, having a total share about 35 percent.
In terms of product, the segment includes Glucose-based, Lactose-based, Sodium chloride-based. And in terms of application, the application includes Food Industry, Medical, etc.
This report delivers a comprehensive overview of the global Natamycin market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Natamycin. The Natamycin market size, estimates, and forecasts are provided in terms of sales volume (MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Natamycin market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Natamycin manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Natamycin Market Report

Report Metric Details
Report Name Natamycin Market
Accounted market size in 2025 US$ 222 million
Forecasted market size in 2032 US$ 341 million
CAGR 6.4%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Glucose-based
  • Lactose-based
  • Sodium chloride-based
by Application
  • Food
  • Medical
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Danisco, DSM, VGP, Handary, AMTECH BIOTECH, Silver-Elephant, Lanzhou Weiri, Langfang Meihua, Zhengzhou New Frey, Chihon, Jiaozuo Joincare, Beijing Oriental Rada, Pucheng Lifecome
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Natamycin manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Natamycin sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Natamycin Market growing?

Ans: The Natamycin Market witnessing a CAGR of 6.4% during the forecast period 2026-2032.

What is the Natamycin Market size in 2032?

Ans: The Natamycin Market size in 2032 will be US$ 341 million.

What is the market share of major companies in Natamycin Market?

Ans: Global top five players hold a share about 50%.

Who are the main players in the Natamycin Market report?

Ans: The main players in the Natamycin Market are Danisco, DSM, VGP, Handary, AMTECH BIOTECH, Silver-Elephant, Lanzhou Weiri, Langfang Meihua, Zhengzhou New Frey, Chihon, Jiaozuo Joincare, Beijing Oriental Rada, Pucheng Lifecome

What are the Application segmentation covered in the Natamycin Market report?

Ans: The Applications covered in the Natamycin Market report are Food, Medical, Others

What are the Type segmentation covered in the Natamycin Market report?

Ans: The Types covered in the Natamycin Market report are Glucose-based, Lactose-based, Sodium chloride-based

1 Natamycin Market Overview
1.1 Product Definition
1.2 Natamycin by Type
1.2.1 Global Natamycin Market Value by Type: 2025 vs 2032
1.2.2 Glucose-based
1.2.3 Lactose-based
1.2.4 Sodium chloride-based
1.3 Natamycin by Application
1.3.1 Global Natamycin Market Value by Application: 2025 vs 2032
1.3.2 Food
1.3.3 Medical
1.3.4 Others
1.4 Global Natamycin Market Size Estimates and Forecasts
1.4.1 Global Natamycin Revenue 2021–2032
1.4.2 Global Natamycin Sales 2021–2032
1.4.3 Global Natamycin Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Natamycin Market Competition by Manufacturers
2.1 Global Natamycin Sales Market Share by Manufacturers (2021–2026)
2.2 Global Natamycin Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Natamycin Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Natamycin, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Natamycin, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Natamycin, Product Types and Applications
2.7 Global Key Manufacturers of Natamycin, Date of Entry into the Industry
2.8 Global Natamycin Market Competitive Situation and Trends
2.8.1 Global Natamycin Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Natamycin Players Market Share by Revenue
2.8.3 Global Natamycin Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Natamycin Market Scenario by Region
3.1 Global Natamycin Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Natamycin Sales by Region: 2021–2032
3.2.1 Global Natamycin Sales by Region: 2021–2026
3.2.2 Global Natamycin Sales by Region: 2027–2032
3.3 Global Natamycin Revenue by Region: 2021–2032
3.3.1 Global Natamycin Revenue by Region: 2021–2026
3.3.2 Global Natamycin Revenue by Region: 2027–2032
3.4 North America Natamycin Market Facts & Figures by Country
3.4.1 North America Natamycin Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Natamycin Sales by Country (2021–2032)
3.4.3 North America Natamycin Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Natamycin Market Facts & Figures by Country
3.5.1 Europe Natamycin Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Natamycin Sales by Country (2021–2032)
3.5.3 Europe Natamycin Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Natamycin Market Facts & Figures by Region
3.6.1 Asia Pacific Natamycin Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Natamycin Sales by Region (2021–2032)
3.6.3 Asia Pacific Natamycin Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Natamycin Market Facts & Figures by Country
3.7.1 Latin America Natamycin Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Natamycin Sales by Country (2021–2032)
3.7.3 Latin America Natamycin Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Natamycin Market Facts & Figures by Country
3.8.1 Middle East and Africa Natamycin Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Natamycin Sales by Country (2021–2032)
3.8.3 Middle East and Africa Natamycin Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Natamycin Sales by Type (2021–2032)
4.1.1 Global Natamycin Sales by Type (2021–2026)
4.1.2 Global Natamycin Sales by Type (2027–2032)
4.1.3 Global Natamycin Sales Market Share by Type (2021–2032)
4.2 Global Natamycin Revenue by Type (2021–2032)
4.2.1 Global Natamycin Revenue by Type (2021–2026)
4.2.2 Global Natamycin Revenue by Type (2027–2032)
4.2.3 Global Natamycin Revenue Market Share by Type (2021–2032)
4.3 Global Natamycin Price by Type (2021–2032)
5 Segment by Application
5.1 Global Natamycin Sales by Application (2021–2032)
5.1.1 Global Natamycin Sales by Application (2021–2026)
5.1.2 Global Natamycin Sales by Application (2027–2032)
5.1.3 Global Natamycin Sales Market Share by Application (2021–2032)
5.2 Global Natamycin Revenue by Application (2021–2032)
5.2.1 Global Natamycin Revenue by Application (2021–2026)
5.2.2 Global Natamycin Revenue by Application (2027–2032)
5.2.3 Global Natamycin Revenue Market Share by Application (2021–2032)
5.3 Global Natamycin Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Danisco
6.1.1 Danisco Company Information
6.1.2 Danisco Description and Business Overview
6.1.3 Danisco Natamycin Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Danisco Natamycin Product Portfolio
6.1.5 Danisco Recent Developments/Updates
6.2 DSM
6.2.1 DSM Company Information
6.2.2 DSM Description and Business Overview
6.2.3 DSM Natamycin Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 DSM Natamycin Product Portfolio
6.2.5 DSM Recent Developments/Updates
6.3 VGP
6.3.1 VGP Company Information
6.3.2 VGP Description and Business Overview
6.3.3 VGP Natamycin Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 VGP Natamycin Product Portfolio
6.3.5 VGP Recent Developments/Updates
6.4 Handary
6.4.1 Handary Company Information
6.4.2 Handary Description and Business Overview
6.4.3 Handary Natamycin Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Handary Natamycin Product Portfolio
6.4.5 Handary Recent Developments/Updates
6.5 AMTECH BIOTECH
6.5.1 AMTECH BIOTECH Company Information
6.5.2 AMTECH BIOTECH Description and Business Overview
6.5.3 AMTECH BIOTECH Natamycin Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 AMTECH BIOTECH Natamycin Product Portfolio
6.5.5 AMTECH BIOTECH Recent Developments/Updates
6.6 Silver-Elephant
6.6.1 Silver-Elephant Company Information
6.6.2 Silver-Elephant Description and Business Overview
6.6.3 Silver-Elephant Natamycin Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Silver-Elephant Natamycin Product Portfolio
6.6.5 Silver-Elephant Recent Developments/Updates
6.7 Lanzhou Weiri
6.7.1 Lanzhou Weiri Company Information
6.7.2 Lanzhou Weiri Description and Business Overview
6.7.3 Lanzhou Weiri Natamycin Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Lanzhou Weiri Natamycin Product Portfolio
6.7.5 Lanzhou Weiri Recent Developments/Updates
6.8 Langfang Meihua
6.8.1 Langfang Meihua Company Information
6.8.2 Langfang Meihua Description and Business Overview
6.8.3 Langfang Meihua Natamycin Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Langfang Meihua Natamycin Product Portfolio
6.8.5 Langfang Meihua Recent Developments/Updates
6.9 Zhengzhou New Frey
6.9.1 Zhengzhou New Frey Company Information
6.9.2 Zhengzhou New Frey Description and Business Overview
6.9.3 Zhengzhou New Frey Natamycin Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Zhengzhou New Frey Natamycin Product Portfolio
6.9.5 Zhengzhou New Frey Recent Developments/Updates
6.10 Chihon
6.10.1 Chihon Company Information
6.10.2 Chihon Description and Business Overview
6.10.3 Chihon Natamycin Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Chihon Natamycin Product Portfolio
6.10.5 Chihon Recent Developments/Updates
6.11 Jiaozuo Joincare
6.11.1 Jiaozuo Joincare Company Information
6.11.2 Jiaozuo Joincare Description and Business Overview
6.11.3 Jiaozuo Joincare Natamycin Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Jiaozuo Joincare Natamycin Product Portfolio
6.11.5 Jiaozuo Joincare Recent Developments/Updates
6.12 Beijing Oriental Rada
6.12.1 Beijing Oriental Rada Company Information
6.12.2 Beijing Oriental Rada Description and Business Overview
6.12.3 Beijing Oriental Rada Natamycin Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Beijing Oriental Rada Natamycin Product Portfolio
6.12.5 Beijing Oriental Rada Recent Developments/Updates
6.13 Pucheng Lifecome
6.13.1 Pucheng Lifecome Company Information
6.13.2 Pucheng Lifecome Description and Business Overview
6.13.3 Pucheng Lifecome Natamycin Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Pucheng Lifecome Natamycin Product Portfolio
6.13.5 Pucheng Lifecome Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Natamycin Industry Chain Analysis
7.2 Natamycin Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Natamycin Production Mode & Process Analysis
7.4 Natamycin Sales and Marketing
7.4.1 Natamycin Sales Channels
7.4.2 Natamycin Distributors
7.5 Natamycin Customer Analysis
8 Natamycin Market Dynamics
8.1 Natamycin Industry Trends
8.2 Natamycin Market Drivers
8.3 Natamycin Market Challenges
8.4 Natamycin Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Natamycin Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Natamycin Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Natamycin Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Natamycin Sales (MT) of Key Manufacturers (2021–2026)
 Table 5. Global Natamycin Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Natamycin Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Natamycin Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Natamycin Average Price (USD/MT) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Natamycin, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Natamycin, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Natamycin, Product Types and Applications
 Table 12. Global Key Manufacturers of Natamycin, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Natamycin Companies by Tier (Tier 1, Tier 2, Tier 3), based on Natamycin Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Natamycin Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Natamycin Sales by Region (MT), 2021–2026
 Table 18. Global Natamycin Sales Market Share by Region (2021–2026)
 Table 19. Global Natamycin Sales by Region (MT), 2027–2032
 Table 20. Global Natamycin Sales Market Share by Region (2027–2032)
 Table 21. Global Natamycin Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Natamycin Revenue Market Share by Region (2021–2026)
 Table 23. Global Natamycin Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Natamycin Revenue Market Share by Region (2027–2032)
 Table 25. North America Natamycin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Natamycin Sales by Country (MT), 2021–2026
 Table 27. North America Natamycin Sales by Country (MT), 2027–2032
 Table 28. North America Natamycin Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Natamycin Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Natamycin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Natamycin Sales by Country (MT), 2021–2026
 Table 32. Europe Natamycin Sales by Country (MT), 2027–2032
 Table 33. Europe Natamycin Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Natamycin Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Natamycin Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Natamycin Sales by Region (MT), 2021–2026
 Table 37. Asia Pacific Natamycin Sales by Region (MT), 2027–2032
 Table 38. Asia Pacific Natamycin Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Natamycin Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Natamycin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Natamycin Sales by Country (MT), 2021–2026
 Table 42. Latin America Natamycin Sales by Country (MT), 2027–2032
 Table 43. Latin America Natamycin Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Natamycin Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Natamycin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Natamycin Sales by Country (MT), 2021–2026
 Table 47. Middle East and Africa Natamycin Sales by Country (MT), 2027–2032
 Table 48. Middle East and Africa Natamycin Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Natamycin Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Natamycin Sales (MT) by Type (2021–2026)
 Table 51. Global Natamycin Sales (MT) by Type (2027–2032)
 Table 52. Global Natamycin Sales Market Share by Type (2021–2026)
 Table 53. Global Natamycin Sales Market Share by Type (2027–2032)
 Table 54. Global Natamycin Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Natamycin Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Natamycin Revenue Market Share by Type (2021–2026)
 Table 57. Global Natamycin Revenue Market Share by Type (2027–2032)
 Table 58. Global Natamycin Price (USD/MT) by Type (2021–2026)
 Table 59. Global Natamycin Price (USD/MT) by Type (2027–2032)
 Table 60. Global Natamycin Sales (MT) by Application (2021–2026)
 Table 61. Global Natamycin Sales (MT) by Application (2027–2032)
 Table 62. Global Natamycin Sales Market Share by Application (2021–2026)
 Table 63. Global Natamycin Sales Market Share by Application (2027–2032)
 Table 64. Global Natamycin Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Natamycin Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Natamycin Revenue Market Share by Application (2021–2026)
 Table 67. Global Natamycin Revenue Market Share by Application (2027–2032)
 Table 68. Global Natamycin Price (USD/MT) by Application (2021–2026)
 Table 69. Global Natamycin Price (USD/MT) by Application (2027–2032)
 Table 70. Danisco Company Information
 Table 71. Danisco Description and Business Overview
 Table 72. Danisco Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 73. Danisco Natamycin Product
 Table 74. Danisco Recent Developments/Updates
 Table 75. DSM Company Information
 Table 76. DSM Description and Business Overview
 Table 77. DSM Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 78. DSM Natamycin Product
 Table 79. DSM Recent Developments/Updates
 Table 80. VGP Company Information
 Table 81. VGP Description and Business Overview
 Table 82. VGP Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 83. VGP Natamycin Product
 Table 84. VGP Recent Developments/Updates
 Table 85. Handary Company Information
 Table 86. Handary Description and Business Overview
 Table 87. Handary Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 88. Handary Natamycin Product
 Table 89. Handary Recent Developments/Updates
 Table 90. AMTECH BIOTECH Company Information
 Table 91. AMTECH BIOTECH Description and Business Overview
 Table 92. AMTECH BIOTECH Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 93. AMTECH BIOTECH Natamycin Product
 Table 94. AMTECH BIOTECH Recent Developments/Updates
 Table 95. Silver-Elephant Company Information
 Table 96. Silver-Elephant Description and Business Overview
 Table 97. Silver-Elephant Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 98. Silver-Elephant Natamycin Product
 Table 99. Silver-Elephant Recent Developments/Updates
 Table 100. Lanzhou Weiri Company Information
 Table 101. Lanzhou Weiri Description and Business Overview
 Table 102. Lanzhou Weiri Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 103. Lanzhou Weiri Natamycin Product
 Table 104. Lanzhou Weiri Recent Developments/Updates
 Table 105. Langfang Meihua Company Information
 Table 106. Langfang Meihua Description and Business Overview
 Table 107. Langfang Meihua Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 108. Langfang Meihua Natamycin Product
 Table 109. Langfang Meihua Recent Developments/Updates
 Table 110. Zhengzhou New Frey Company Information
 Table 111. Zhengzhou New Frey Description and Business Overview
 Table 112. Zhengzhou New Frey Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 113. Zhengzhou New Frey Natamycin Product
 Table 114. Zhengzhou New Frey Recent Developments/Updates
 Table 115. Chihon Company Information
 Table 116. Chihon Description and Business Overview
 Table 117. Chihon Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 118. Chihon Natamycin Product
 Table 119. Chihon Recent Developments/Updates
 Table 120. Jiaozuo Joincare Company Information
 Table 121. Jiaozuo Joincare Description and Business Overview
 Table 122. Jiaozuo Joincare Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 123. Jiaozuo Joincare Natamycin Product
 Table 124. Jiaozuo Joincare Recent Developments/Updates
 Table 125. Beijing Oriental Rada Company Information
 Table 126. Beijing Oriental Rada Description and Business Overview
 Table 127. Beijing Oriental Rada Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 128. Beijing Oriental Rada Natamycin Product
 Table 129. Beijing Oriental Rada Recent Developments/Updates
 Table 130. Pucheng Lifecome Company Information
 Table 131. Pucheng Lifecome Description and Business Overview
 Table 132. Pucheng Lifecome Natamycin Sales (MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 133. Pucheng Lifecome Natamycin Product
 Table 134. Pucheng Lifecome Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Natamycin Distributors List
 Table 138. Natamycin Customers List
 Table 139. Natamycin Market Trends
 Table 140. Natamycin Market Drivers
 Table 141. Natamycin Market Challenges
 Table 142. Natamycin Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Natamycin
 Figure 2. Global Natamycin Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Natamycin Market Share by Type: 2025 & 2032
 Figure 4. Glucose-based Product Picture
 Figure 5. Lactose-based Product Picture
 Figure 6. Sodium chloride-based Product Picture
 Figure 7. Global Natamycin Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Natamycin Market Share by Application: 2025 & 2032
 Figure 9. Food
 Figure 10. Medical
 Figure 11. Others
 Figure 12. Global Natamycin Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Natamycin Market Size (US$ Million), 2021–2032
 Figure 14. Global Natamycin Sales (MT), 2021–2032
 Figure 15. Global Natamycin Average Price (USD/MT), 2021–2032
 Figure 16. Natamycin Report Years Considered
 Figure 17. Natamycin Sales Share by Manufacturers in 2025
 Figure 18. Global Natamycin Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Natamycin Players: Market Share by Revenue in Natamycin in 2025
 Figure 20. Natamycin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Natamycin Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Natamycin Sales Market Share by Country (2021–2032)
 Figure 23. North America Natamycin Revenue Market Share by Country (2021–2032)
 Figure 24. U.S. Natamycin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Natamycin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Natamycin Sales Market Share by Country (2021–2032)
 Figure 27. Europe Natamycin Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Natamycin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Natamycin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Natamycin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Natamycin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Natamycin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Natamycin Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Natamycin Revenue Market Share by Region (2021–2032)
 Figure 35. China Natamycin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Natamycin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Natamycin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Natamycin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Natamycin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Natamycin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Indonesia Natamycin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Thailand Natamycin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Malaysia Natamycin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Latin America Natamycin Sales Market Share by Country (2021–2032)
 Figure 45. Latin America Natamycin Revenue Market Share by Country (2021–2032)
 Figure 46. Mexico Natamycin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Brazil Natamycin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Argentina Natamycin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Middle East and Africa Natamycin Sales Market Share by Country (2021–2032)
 Figure 50. Middle East and Africa Natamycin Revenue Market Share by Country (2021–2032)
 Figure 51. Turkey Natamycin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Saudi Arabia Natamycin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. UAE Natamycin Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Global Sales Market Share of Natamycin by Type (2021–2032)
 Figure 55. Global Revenue Market Share of Natamycin by Type (2021–2032)
 Figure 56. Global Natamycin Price (USD/MT) by Type (2021–2032)
 Figure 57. Global Sales Market Share of Natamycin by Application (2021–2032)
 Figure 58. Global Revenue Market Share of Natamycin by Application (2021–2032)
 Figure 59. Global Natamycin Price (USD/MT) by Application (2021–2032)
 Figure 60. Natamycin Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc